Study Reveals How HIV and Opioids Damage Brain DNA, Pointing to a Potential Existing Treatment
Researchers at Texas A&M Health discovered that HIV and opioids together disrupt the brain's DNA repair system, causing chronic inflammation and cognitive decline. However, a currently FDA-approved drug for multiple sclerosis may help reverse these effects.
🧠AI AnalysisPhoto: Medical Xpress
Key points
- HIV and opioids combine to disrupt the brain's DNA repair system, leading to chronic inflammation and cognitive impairment.
- Researchers at Texas A&M Health utilized lab-grown cells, animal models, and postmortem tissues to uncover this underlying mechanism.
- An FDA-approved multiple sclerosis drug, dimethyl fumarate, showed potential in laboratory models to restore DNA repair and calm harmful immune signaling.
Individuals managing HIV frequently experience memory challenges, poor focus, and cognitive difficulties despite the remarkable life-extending efficacy of antiretroviral therapies. For patients who are also prescribed opioids for chronic pain or who face risks from injection drug use, these neurological struggles are often magnified. Until now, the exact cellular mechanisms driving this intersection remained poorly understood by scientists.
A team from Texas A&M Health published a study in Cell Death and Disease exploring how HIV and opioids impact the brain. By analyzing lab-grown brain immune cells, genetically modified mice, and postmortem human brain tissues, the researchers found that the HIV protein Tat and morphine combine to trigger the brain's DNA damage response while hindering proper repair processes. This creates a persistent cycle of cellular injury, altered epigenetic markers, and sustained inflammation that impairs nerve function.
To see if this damage could be undone, the team tested dimethyl fumarate (DMF), an FDA-approved multiple sclerosis medication recognized for its anti-inflammatory properties. In laboratory models, DMF successfully restored the brain's DNA repair coordination and quieted harmful immune signals. Study authors note that this approach addresses the root cellular problem rather than merely managing subsequent inflammation.
What to know: While the findings offer a promising avenue for protecting cognitive health in patients living with HIV and opioid exposure, the study was conducted using laboratory models and postmortem tissues rather than human clinical trials. Patients should always talk to a doctor regarding personal medical decisions and treatment plans.
Source Medical Xpress — medicalxpress.com/news/2026-11-potential-brain-hiv-opioid.html ↗
Read next
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…